Conclusions . Ad nosin infusion is saf . Vasodilator and n gativ dromotropic sid ff cts ar g n rally w ll tol rat d . S rious sid ff cts ar r lativ ly rar , and th y r v rs with t rmination of ad nosin infusion . Int rpr tabl radionuclid studi s w r obtain d in 98 .7% of pati nts and aminophyllin r v rsal was s ldom r quir d .
(I Ain Coll Cardiol 1994,23 .384-9)
allowing xtrac liular accumulation of ndog nously produc d ad nosin . Dir ct intrav nous infusion of ad nosin has also b n shown to incr as coronary blood flow (9, 10) . Additionally, in combination with thallium-201 p rfusion imaging, it has a s nsitivity and sp cificity for d t cting coronary art ry dis as comparabl to that obtain d with x rcis thallium-201 scintigraphy (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . Ad nosin produc s maximal myocardial hyp r mia dir ctly, has a rapid ons t of action and an ultrashort half-lif (< 10 s) that allows dos titration and rapid r v rsal of sid ff cts (22) . Th Ad noscan Multic nt r Trial R gistry was a prosp ctiv , op n lab l phas III trial using fix d dos , continuous intrav nous infusion of ad nosin in pati nts r f rr d for clinically indicat d diagnostic radionuclid p rfusion imaging who w r unabl to p rform x rcis str ss . From this r gistry, w r port on th fr qu ncy of arly adv rs v nts (during and imm diat ly aft r ad nosin infusion), th ir s v rity and th r spons r quir d in 9,256 cons cutiv pati nts . In 1,067 pati nts, w also r cord d d lay d or r curr nt adv rs v nts during th imm diat 24-h p riod aft r infusion . 
R sults
Pati nt charact ristics . Tabl l lists th charact ristics of th pati nts nroll d in this protocol. In g n ral, th s charact ristics ar typical of pati nts r f rr d for diagnostic radionuclid p rfusion imaging who ar unabl to p rform x rcis str ss . H ynatnic r spons . Figur 2 shows th h art rat and blood pr ssur r spons at bas lin and during th 6 min of ad nosin infusion in pati nts compl ting th 6-min infusion . Th typical h modynamic r spons was a mod st r ductio . i n systolic and diastolic blood pr ssur with a comp nsatory incr as in h art rat . S v r hypot nsion or paradoxic hyp rt nsion was infr qu nt in th s pati nts, as w ll as in thos who had a dos r duction or t rmination . H art rat incr as d significantly during ach minut of infusion xc pt b tw n th 5th and 6th min. 27.3 mm Hg and diastolic blood pr ssur d cr as d from 79.9 11 .9 to 71 .9 ± 14 .2 mm Hg .
Protocol compl tion . As shown in Figur 3, th 6-min 140-jug/kg p r thin ad nosin infusion protocol was compl t d in 7,226 pati nts (80%), r quir d dos r duction in 1 .165 pati nts (13%) and was t rminat d arly in 664 pati nts (7%) . Aminophyllin was giv n to 71 pati nts (0.8%) . Dspit ad nosin dos r duction or arly t rmination, radioisotop was inj ct d and th infusion continu d for an additional p riod in 98 .7% of pati nts . In som pati nts . th occurr nc of significant ECG chang s or ch st pain was th r ason for th arly t rmination or dos r duction . Figur 4 . Th r lativ risk of having any sid ff cts during adnosin infusion as d t rmin d by st pwis logistic r gr ssion analysis was mod stly incr as d in wom n, pati nts whos body w ight was high r than th m dian body w ight and thos whos ag was l ss than th m dian ag .
but in all cas s, th pisod s had alr ady s lf-t rminat d . Th r w r no diff r nc s in th occurr nc of isch mia (p rfusion d f cts or isch mic ECG chang s) b tw n pati nts with and without AV block . Thus, th s pisod s of AV nod block probably r pr s nt a dir ct ad nosin ff ct on th conduction syst m rath r than a manif station of isch mia .
Univariat analysis of bas lin clinical and ECG charact ristics, m dications (including b ta-adr n rgic and calcium block rs) and pati nt ag , nt r d as a continuous variabl , id ntifi d only ag as a pr dictor of AV block . S parat analys s w r also p rform d nt ring ag as a discr t variabl , starting at ag :550 or >50 y ars and incr asing by 5-y ar int rvals to ag 75 y ars . Th b st s paration by ag occurr d for pati nts <70 y ars (63% of all pati nts t st d) v rsus pati nts :00 y ars (37%) (AV block incid nc of 7 .05% vs . 9 .44%, p < 0 .001) . Wh n this ag dichotomy was nt r d into th logistic r gr ssion analysis mod l, th r lativ risk for AV nod block was mod stly incr as d (odds ratio 1 .37, 95% confid nc int rvals of 1 .17 to 1 .61) . B ta-and calcium chann l block rs and conduction syst m abnormaliti s on th bas lin ECG w r not pr dictors of AV nod block .
D lay d or r curr nt adv rs v nts. i n th 1,067 pati nts monitor d for 24 h, th r w r 142 d lay d v nts and 107 r curr nt v nts r port d for a total of 23% . Of th 142 d lay d v nts, 21 v nts in 17 pati nts w r consid r d pot ntially significant and includ d h adach (n = 6), gastroint stinal discomfort (n = 3), xtr mity discomfort (n 3), hypot nsion (n = 2), ch st pain (n = 2), par sth sia (n I), asth nia (n = 1), bradycardia (n = I), lighth ad dn ss/dizzin ss (n = 1) and inability to walk (n = I) . Th majority of th s v nts r solv d spontan ously or with minimal int rv ntion and w r judg d by physicians to b unr lat d or not cl arly du to th ad nosin infusion . Consid ring that pati nts und rgoing pharmacologic str ss t sting ar g n rally old r and mor d bilitat d than thos und rgoing x rcis str ss, th s r sults sugg st that both dipyridamol and ad nosin ar saf and that s v r cardiac v nts ar rar using ith r ag nt . Ad nosin off rs JACC Vol. 23, No . 2 F bruary 1994 :384-9 th following advantag s : rapid ons t of action, prov n pot ncy as a dir ct coronary vasodilator, th ability to rapidly modulat its pharmacologic ff cts through dos adjustm nt, short half-lif and a low incid nc of aminophyllin administration for r v rsal .
Incid nc of adv rs v nts by ag , g nd r and body w ight. During intrav nous dipyridamol infusion, a high r fr qu ncy of total sid ff cts has b n r port d in wom n r lativ to m n and in ob s pati nts (7, 23) . W r port similar findings with th us of ad nosin . Young r pati nts w r mor lik ly to r port adv rs v nts than w r old r pati nts . Th r ason for this ag diff r nc is not obvious and may b r lat d to diff r nc s in p rc ption, ad nosin r c ptor s nsitivity or ad nosin m tabolism .
Atriov ntricular block . This occurr d in 7 .6%% of pati nts but t rminat d spontan ously in most . and th r w r no prolong d pisod s in any pati nt . Th incr as in r lativ risk in pati nts L-70 y ars (9 .44%) v rsus pati nts <70 y ars (7 .05%) do s not allow pr diction of risk in an individual pati nt . Pati nts taking b ta-or calcium chann l block rs w r not at incr as d risk .
Th obs rvation that p rfusion d f cts and isch mic ECG chang s did not pr dict AV block sugg sts that th block was a transi nt and dir ct pharmacologic ff ct of ad nosin on th AV nod . This is w ll known and und rli s th curr nt indication of ad nosin as an ff ctiv drug for tr atm nt of suprav ntricular tachycardia (22) . Sp cial car must b tak n to infus ad nosin at a constant rat during its us with radionuclid p rfusion imaging . It is optimally infus d by using an accurat and pr f rably comput riz d pump syst m that allows th infusion rat to b d cr as d without b ing compl t ly stopp d . Stopping th infusion compl t ly b for r ducing th dos r sults in a rapid r v rsal of th hyp r mia and it may tak I to 2 min to r ach maximal hyp r mia at th n w dos . Rapid inj ction and flushing of th radiopharmac utical ag nt through th intra- Conclusions. Th s prosp ctiv findings in a larg group of pati nts stablish th ov rall saf ty of ad nosin pharmacologic hyp r mia in conjunction with radionuclid p rfusion imaging.
Add ndum
Sinc compl tion of nrollm nt of th 9,256 pati nts pr s nt d in this r port, approximat ly 1,800 additional pati nts hav b n nroll d and th r was on r port d d ath aft r a total pati nt nrollm nt of 1 1,000 .
App ndix ,Study Parfit-ipapas
